Insulin Receptors and Downstream Substrates Associate with Membrane Microdomains after Treatment with Insulin or Chromium(III) Picolinate

Cell Biochemistry and Biophysics

Volumn 62, Issue 3, 2012, Pages 441-450

  Al Qatati, Abeer ^a   Winter, Peter W ^a   Wolf Ringwall, Amber L ^a   Chatterjee, Pabitra B ^a   van Orden, Alan K ^a   Crans, Debbie C ^a   Roess, Deborah A ^a   Barisas, B George ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Chromium; Fourier transform infrared spectroscopy; Insulin; Lipid order; Membrane microdomain; Picolinate; Reverse micelle; Single particle tracking

Indexed keywords

ANTIDIABETIC AGENT; DETERGENT; DI 4 ANEPPDHQ; DI-4-ANEPPDHQ; INSULIN; INSULIN RECEPTOR; IRON CHELATING AGENT; PICOLINIC ACID; PICOLINIC ACID DERIVATIVE; PYRIDINIUM DERIVATIVE;

ANIMAL; ARTICLE; CELL LINE; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; ENZYME SPECIFICITY; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; RAT;

ANIMALS; CELL LINE; DETERGENTS; HYPOGLYCEMIC AGENTS; INSULIN; IRON CHELATING AGENTS; MEMBRANE MICRODOMAINS; PHOSPHORYLATION; PICOLINIC ACIDS; PROTEIN BINDING; PYRIDINIUM COMPOUNDS; RATS; RECEPTOR, INSULIN; SUBSTRATE SPECIFICITY;

RATTUS;

EID: 84858705863     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9326-x     Document Type: Article

References (65)

1. Ishikawa, Y., Otsu, K., & Oshikawa, J. (2005). Caveolin; different roles for insulin signal? Cellular Signalling, 17, 1175-1182.
2. Nystrom, F., Chen, H., Cong, L.-N., Li, Y., & Quon, M. (1999). Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Molecular Endocrinology, 13, 2013-2024.
3. Kim, K.-B., Kim, B.-W., Choo, H.-J., Kwon, Y.-C., Ahn, B.-Y., Choi, J.-S., et al. (2009). Proteome analysis of adipocyte lipid rafts reveals that gC1qR plays essential roles in adipogenesis and insulin signal transduction. Proteomics, 9, 2373-2382.
4. Czech, M. (2000). PIP2 and PIP3: Complex roles at the cell surface. Cell, 100, 603-606.
5. Maffucci, T., Brancaccio, A., Piccolo, E., Stein, R. C., & Falasca, M. (2003). Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO Journal, 22, 4178-4189.
6. Müller, G., Jung, C., Wied, S., Welte, S., & Frick, W. (2001). Insulin-mimetic signaling by the sulfonylurea glimepiride and phosphoinositolglycans involves distinct mechanisms for redistribution of lipid raft components. Biochemistry, 40, 14603-14620.
7. Yamaguchi, H., Shiraishi, M., Fukami, K., Tanabe, A., Ikeda-Matsuo, Y., Naito, Y., et al. (2009). MARCKS regulates lamellipodia formation induced by IGF-I via association with PIP2 and beta-actin at membrane microdomains. Journal of Cellular Physiology, 220, 748-755.
8. Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., et al. (2000). CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature, 407, 202-207.
9. Vincent, J. B. (2010). Chromium: Celebrating 50 years as an essential element? Dalton Transactions, 39, 3787-3794.
10. Anderson, R. A. (1998). Chromium, glucose intolerance and diabetes. Journal of the American College of Nutrition, 17, 548-555.
11. Anderson, R., Polansky, M., Bryden, N., & Canary, J. (1991). Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. American Journal of Clinical Nutrition, 54, 909-916.
12. Martin, J., Wang, Z. Q., Zhang, X. H., Wachtel, D., Volaufova, J., Matthews, D. E., et al. (2006). Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care, 29, 1826-1832.
13. Yang, X., Palanichamy, K., Ontko, A. C., Rao, M. N. A., Fang, C. X., Ren, J., et al. (2005). A newly synthetic chromium complex-chromium(phenylalanine)3-improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Letters, 579, 1458-1464.
14. Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B., et al. (2006). Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Molecular Endocrinology, 20, 857-870.
15. Chen, W.-Y., Chen, C.-J., Liu, C.-H., & Mao, F. C. (2009). Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes, Obesity & Metabolism, 11, 293-303.
16. Pattar, G. R., Tackett, L., Liu, P., & Elmendorf, J. S. (2006). Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutation Research, 610, 93-100.
17. Wang, Z. Q., Zhang, X. H., Russell, J. C., Hulver, M., & Cefalu, W. T. (2006). Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR: LA-cp rats. Journal of Nutrition, 136, 415-420.
18. Wang, H., Kruszewski, A., & Brautigan, D. L. (2005). Cellular chromium enhances activation of insulin receptor kinase. Biochemistry, 44, 8167-8175.
19. Ravina, A., Slezak, L., Mirsky, N., Bryden, N. A., & Anderson, R. A. (1999). Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabetic Medicine, 16, 164-167.
20. Anderson, R. A., Cheng, N., Bryden, N. A., Polansky, M. M., Chi, J., & Feng, J. (1997). Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes, 46, 1786-1791.
21. Cheng, H.-H., Lai, M.-H., Hou, W.-C., & Huang, C.-L. (2004). Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. Journal of Agricultural and Food Chemistry, 52, 1385-1389.
22. Anderson, R. A., Polansky, M. M., Bryden, N. A., Bhathena, S. J., & Canary, J. J. (1987). Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism, 36, 351-355.
23. Davis, C. M., & Vincent, J. B. (1997). Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry, 36, 4382-4385.
24. Peterson, R. L., Banker, K. J., Garcia, T. Y., & Works, C. F. (2008). Isolation of a novel chromium(III) binding protein from bovine liver tissue after chromium(VI) exposure. Journal of Inorganic Biochemistry, 102, 833-841.
25. Evans, G. W., & Bowman, T. D. (1992). Chromium picolinate increases membrane fluidity and rate of insulin internalization. Journal of Inorganic Biochemistry, 46, 243-250.
26. Lingwood, D., & Simons, K. (2010). Lipid rafts as a membrane-organizing principle. Science, 327, 46-50.
27. Evans, G. W., & Pouchnik, D. J. (1993). Composition and biological activity of chromium-pyridine carboxylate complexes. Journal of Inorganic Biochemistry, 49, 177-187.
28. Niemann, A., Bossek, U., Haselhorst, G., Wieghardt, K., & Nuber, B. (1996). Synthesis and characterization of six-coordinate nitrido complexes of vanadium(V), chromium(V), and manganese(V). Isolation of a dinuclear, mixed-valent mu-nitrido chromium(III)/chromium(V) species. Inorganic Chemistry, 35, 906-915.
29. Daumas, F., Destainville, N., Millot, C., Lopez, A., Dean, D., & Salomé, L. (2003). Confined diffusion without fences of a G protein coupled receptor as revealed by single particle tracking. Biophysical Journal, 84, 356-366.
30. Barisas, B. G., Smith, S. M., Liu, J., Song, J., Hagen, G. M., Pecht, I., et al. (2007). Compartmentalization of the Type I Fc epsilon receptor and MAFA on mast cell membranes. Biophysical Chemistry, 126, 209-217.
31. Saxton, M. J. (1997). Single-particle tracking: The distribution of diffusion coefficients. Biophysical Journal, 72, 1744-1753.
32. Roess, D. A., & Smith, S. M. L. (2003). Self-association and raft localization of functional luteinizing hormone receptors. Biology of Reproduction, 69, 1765-1770.
33. Christian, A. E., Haynes, M. P., Phillips, M. C., & Rothblat, G. H. (1997). Use of cyclodextrins for manipulating cellular cholesterol content. Journal of Lipid Research, 38, 2264-2272.
34. Fogarty, K., McPhee, J., Scott, E., & van Orden, A. (2009). Probing the ionic atmosphere of single-stranded DNA using continuous flow capillary electrophoresis and fluorescence correlation spectroscopy. Analytical Chemistry, 81, 465-472.
35. Chiantia, S., Ries, J., & Schwille, P. (2009). Fluorescence correlation spectroscopy in membrane structure elucidation. Biochimica et Biophysica Acta, 1788, 225-233.
36. Ruan, Q., Chen, Y., Gratton, E., Glaser, M., & Mantulin, W. W. (2002). Cellular characterization of adenylate kinase and its isoform: Two-photon excitation fluorescence imaging and fluorescence correlation spectroscopy. Biophysical Journal, 83, 3177-3187.
37. Ries, J., & Schwille, P. (2008). New concepts for fluorescence correlation spectroscopy on membranes. Physical Chemistry Chemical Physics, 10, 3487-3497.
38. Schwille, P., Haupts, U., Maiti, S., & Webb, W. W. (1999). Molecular dynamics in living cells observed by fluorescence correlation spectroscopy with one- and two-photon excitation. Biophysical Journal, 77, 2251-2265.
39. Chen, Y., Munteanu, A. C., Huang, Y.-F., Phillips, J., Zhu, Z., Mavros, M., et al. (2009). Mapping receptor density on live cells by using fluorescence correlation spectroscopy. Chemistry A European Journal, 15, 5327-5336.
40. Singh, P., Paila, Y. D., & Chattopadhyay, A. (2007). Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin 1A receptor: Implications in SLOS. Biochemical and Biophysical Research Communications, 358, 495-499.
41. Stahla, M. L., Baruah, B., James, D. M., Johnson, M. D., Levinger, N. E., & Crans, D. C. (2008). 1H NMR studies of aerosol-OT reverse micelles with alkali and magnesium counterions: Preparation and analysis of MAOTs. Langmuir, 24, 6027-6035.
42. Jin, L., Millard, A., Wuskell, J., Clark, H., & Loew, K. (2005). Cholesterol-enriched lipid domains can be visualized by di-4-ANEPPDHQ with linear and nonlinear optics. Biophysical Journal, 90, 2563-2575.
43. Jin, L., Millard, A. C., Wuskell, J. P., Dong, X., Wu, D., Clark, H. A., et al. (2006). Characterization and application of a new optical probe for membrane lipid domains. Biophysical Journal, 90, 2563-2575.
44. Wang, Y., Jing, G., Perry, S., Bartoli, F., & Tatic-Lucic, S. (2009). Spectral characterization of the voltage-sensitive dye di-4-ANEPPDHQ applied to probing live primary and immortalized neurons. Optics Express, 17, 984-990.
45. Demchenko, A. P., Mély, Y., Duportail, G., & Klymchenko, A. S. (2009). Monitoring biophysical properties of lipid membranes by environment-sensitive fluorescent probes. Biophysical Journal, 96, 3461-3470.
46. Owen, D. M., Lanigan, P. M. P., Dunsby, C., Munro, I., Grant, D., Neil, M. A. A., et al. (2006). Fluorescence lifetime imaging provides enhanced contrast when imaging the phase-sensitive dye di-4-ANEPPDHQ in model membranes and live cells. Biophysical Journal, 90, 80-82.
47. Crans, D. C., Baruah, B., Ross, A., & Levinger, N. E. (2009). Impact of confinement and interfaces on coordination chemistry: Using oxovanadate reactions and proton transfer reactions as probes in reverse micelles. Coordination Chemistry Reviews, 253, 2178-2185.
48. Maitra, A. (1984). Determination of size parameters of water-Aerosol OT-oil reverse micelles from their nuclear magnetic resonance data. The Journal of Physical Chemistry, 88, 5122-5125.
49. Crans, D. C., Trujillo, A. M., Bonetti, S., Rithner, C. D., Baruah, B., & Levinger, N. E. (2008). Penetration of negatively charged lipid interfaces by the doubly deprotonated dipicolinate. Journal of Organic Chemistry, 73, 9633-9640.
50. Karlsson, M., Thorn, H., Danielsson, A., Stenkula, K. G., Öst, A., Gustavsson, J., et al. (2004). Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. European Journal of Biochemistry, 271, 2471-2479.
51. Nguyen, A., Mulyani, I., Levina, A., & Lay, P. A. (2008). Reactivity of chromium(III) nutritional supplements in biological media: An X-ray absorption spectroscopic study. Inorganic Chemistry, 47, 4299-4307.
52. Jeffcoat, A. R. (2002) [14C]-Chromium picolinate monohydrate: Disposition and metabolism in rats and mice. Technical Report RTI/64U-6855/15P, Research Triangle Institute, Research Triangle Park, NC.
53. Hepburn, D. D. D., & Vincent, J. B. (2002). In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chemical Research in Toxicology, 15, 93-100.
54. Lugo, M. L., & Lubes, V. R. (2007). Ternary complex formation between chromium(III)-picolinic acid, chromium(III)-dipicolinic acid, and small blood serum bioligands. Journal of Chemical and Engineering Data, 52, 1217-1222.
55. Raja, N. S., Sankaranarayanan, K., Dhathathreyan, A., & Nair, B. U. (2011). Interaction of chromium(III) complexes with model lipid bilayers: Implications on cellular uptake. Biochimica et Biophysica Acta, 1808, 332-340.
56. Pilch, P. F., Thompson, P. A., & Czech, M. P. (1980). Coordinate modulation of d-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proceedings of the National Academy of Sciences of the United States of America, 77, 915-918.
57. Muller, S., Denet, S., Candiloros, H., Barrois, R., Wiernsperger, N., Donner, M., et al. (1997). Action of metformin on erythrocyte membrane fluidity in vitro and in vivo. European Journal of Pharmacology, 337, 103-110.
58. Freisleben, H.-J., Ruckert, S., Wiernsperger, N., & Zimmer, G. (1992). The effects of glucose, insulin and metformin on the order parameters of isolated red cell membranes: An electron paramagnetic resonance spectroscopic study. Biochemical Pharmacology, 43, 1185-1194.
59. Matthaei, S., Hamann, A., Klein, H. H., Benecke, H., Kreymann, G., Flier, J. S., et al. (1991). Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes, 40, 850-857.
60. Hundal, H., Ramlal, T., Reyes, R., Leiter, L., & Klip, A. (1992). Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology, 131, 1165-1173.
61. Pike, L. J., & Miller, J. M. (1998). Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. Journal of Biological Chemistry, 273, 22298-22304.
62. Huby, R. D., Dearman, R. J., & Kimber, I. (1999). Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. Journal of Biological Chemistry, 274, 22591-22596.
63. Sheets, E., Holowka, D., & Baird, B. (1999). Membrane organization in immunoglobulin E receptor signaling. Current Opinion in Chemical Biology, 3, 95-99.
64. Reis-Sobreiro, M., Gajate, C., & Mollinedo, F. (2009). Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene, 28, 3221-3234.
65. Janes, P., Ley, S., & Magee, A. (1999). Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. Journal of Cell Biology, 147, 447-461.